Emergency Response

When emergencies occur, re-establishing health services is a critical priority. To assist our customers in emergency or disaster situations, IDA has a 24-hour hotline that can be reached by calling +31-6 54387985.

IEHK 2017

In addition to our standard range of essential medicines, IDA provides the Interagency Emergency Health Kit (IEHK 2017). The kit and other in-stock products can normally be available for shipment within 48 hours. Many relief organisations and national authorities see the IEHK as a reliable, standardised, and affordable source of the products most needed in disaster situations. The contents of the kit are determined by the World Health Organisation (WHO). The IEHK is designed for use when there is a disruption of medical services. It is intended to fill the gap until normal supply and service mechanisms are restored. The contents of one IEHK treats 10.000 people for a three-month period.


IDA can also provide product kits for specific emergency health situations. We supply three different cholera care kits designed to treat patients within a health facility or at the community level. The kits contain IV fluids, oral rehydration salts, and a large assortment of medicines and consumable products. Cholera beds are also available, either as part of a kit or separately. The cholera kits are designed to help prepare for an outbreak and to support the first month of the response. 


Severe acute malnutrition is characterised by a very low weight compared to height, visible wasting, and/or nutritional oedema. The SAM/PED 2020 kit we supply includes medicines, renewables (single use) and equipment to treat paediatric diseases, next to the treatment of severe acute malnutrition. This prepacked kit is designed for use where there is disruption of medical supplies in emergency settings to fill the gap until the medical supply mechanisms are restored.


We are currently supplying COVID-19-related products (PPE, diagnostic tests and others) in response to the COVID-19 pandemic. Please see our COVID-19 page for more information.